Now in our 13th year of bringing you beautiful imagery from biomedical science every day

Search the archive of over 4000 images

Bactericidal Cancer Drug
16 November 2015

Bactericidal Cancer Drug

The threat of multidrug-resistant bacteria is ever growing, but the list of new antibiotics is certainly not. Researchers are thus starting to turn to existing drugs that might have additional infection-fighting potential. One such drug is tamoxifen, which is used by hundreds of thousands of patients for treating certain breast cancers. Aside from tamoxifen’s cancer-suppressing activity, the drug is known to modulate the production of certain fats called sphingolipids. It just so happens that sphingolipids modulate the behaviour of immune cells called neutrophils, which are adept at disposing of bacteria. Researchers have now shown that tamoxifen boosts neutrophils’ antibacterial activities including phagocytosis – the gobbling-up of the bugs – and production of neutrophil extracellular traps, or NETS (pictured) – long sticky strands of chromatin expelled from neutrophils that ensnare and kill bacteria. Indeed, in mice infected with MRSA, a major hospital 'superbug', tamoxifen treatment significantly boosted bacterial clearance.

Written by Ruth Williams

Search The Archive

Submit An Image

Follow on Tumblr

Follow on Instagram

What is BPoD?

BPoD stands for Biomedical Picture of the Day. Managed by the MRC Laboratory of Medical Sciences until Jul 2023, it is now run independently by a dedicated team of scientists and writers. The website aims to engage everyone, young and old, in the wonders of biology, and its influence on medicine. The ever-growing archive of more than 4000 research images documents over a decade of progress. Explore the collection and see what you discover. Images are kindly provided for inclusion on this website through the generosity of scientists across the globe.

Read More

BPoD is also available in Catalan at www.bpod.cat with translations by the University of Valencia.